Christopher J. Calamari - Feb 28, 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Christopher J. Calamari by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Feb 28, 2022
Transactions value $
-$373,281
Form type
4
Date filed
3/2/2022, 06:33 PM
Previous filing
Feb 23, 2022
Next filing
Jul 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Tax liability -$290K -2.37K -8.24% $122.41 26.4K Feb 28, 2022 Direct
transaction ABT Common shares without par value Sale -$83.4K -706 -2.68% $118.15 25.7K Mar 1, 2022 Direct
holding ABT Common shares without par value 30.2K Feb 28, 2022 The Calamari Family Trust
holding ABT Common shares without par value 101 Feb 28, 2022 Profit Sharing Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2022.

Remarks:

The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).